Abstract
The spectrum of the nervous system diseases in which administration of B vitamins is pathogenetically justified, especially thiamine, pyridoxine and cyanocobalamin, is varied. The diseases include dysmetabolic, toxic, infectious lesions of the central and peripheral nervous system, neurological manifestation of degenerative spine diseases, and pain syndromes. B-group vitamins possess neuroprotective and analgesic properties, can be combined with other pharmacological classes of drugs, thus allowing to achieve a positive therapeutic effect with a lower dose of those and reducing the risk of adverse effects.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
